These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Finally, a promising model for high-altitude pulmonary edema (HAPE)-A Mountaineers' Malady. Nikinmaa M Acta Physiol (Oxf); 2020 Jun; 229(2):e13472. PubMed ID: 32243073 [No Abstract] [Full Text] [Related]
14. [Pulmonary hypertension and lung edema at high altitude. Role of endothelial dysfunction and fetal programming]. Schwab M; Allemann Y; Rexhaj E; Rimoldi SF; Sartori C; Scherrer U Medicina (B Aires); 2012; 72(2):150-7. PubMed ID: 22522859 [TBL] [Abstract][Full Text] [Related]
15. Comment on "Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema". Sikri G; Bhattachar S Mediators Inflamm; 2017; 2017():8546027. PubMed ID: 28270701 [No Abstract] [Full Text] [Related]
16. Pathophysiology of acute mountain sickness and high altitude pulmonary oedema: an hypothesis. Sutton JR; Lassen N Bull Eur Physiopathol Respir; 1979; 15(5):1045-52. PubMed ID: 389325 [TBL] [Abstract][Full Text] [Related]
17. Response to: Comment on "Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema". Hilty MP; Zügel S; Schoeb M; Auinger K; Dehnert C; Maggiorini M Mediators Inflamm; 2018; 2018():8036759. PubMed ID: 29853793 [No Abstract] [Full Text] [Related]